UPCUniverse Pharmaceuticals INC$1.50Nov 13 close-4.2%1M-63.9%6M-44.0%1Y-58.9%5Y-100.0%

Overview Financials Earnings Peers Projection Compare

Loading company

Every figure taken straight from a company’s own SEC filings, with the checks behind each grade shown — and whatever could not be found named rather than hidden.

Appearance

Product

Screener
Earnings calendar
Watchlists
Portfolios

Browse

Rankings
Free this week
Industries
Curated lists
Fund managers

Company

About
How the grade works
Glossary
Pricing
Contact

Legal

Terms of service
Privacy policy
Disclaimer
Cookie policy

InspectStocks describes businesses using their own reported figures. It is not investment advice and does not recommend buying or selling anything.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Universe Pharmaceuticals INC (UPC) latest earnings — what was reported — InspectStocks

UPCUniverse Pharmaceuticals INC$1.50Nov 13 close-4.2%1M-63.9%6M-44.0%1Y-58.9%5Y-100.0%

Compare

Overview Financials Earnings Peers Projection Compare

Universe Pharmaceuticals INC

UPC · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic

D-

Grade D-Mixed

Compare

$1.50-4.2%Nov 13 close

Figures through September 30, 2025, from the 20-F filed January 29, 2026

Past performance

1W: +7.9%
1M: -63.9%
3M: -73.5%
6M: -44.0%
1Y: -58.9%
5Y: -100.0%

The latest quarter we hold for Universe Pharmaceuticals INC

From the company’s own 6-K filing.

Earnings calls

Universe Pharmaceuticals INC has no earnings call transcript available.

The quote and the company description come from the 6-K Universe Pharmaceuticals INC filed on July 29, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.